Overview

A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the antiviral activity and safety of VX-787 given to healthy adult volunteers that have been inoculated with the influenza virus.
Phase:
Phase 2
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated